{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:24:32Z","timestamp":1774085072654,"version":"3.50.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.critrevonc.2010.07.005","type":"journal-article","created":{"date-parts":[[2010,8,9]],"date-time":"2010-08-09T08:24:32Z","timestamp":1281342272000},"page":"127-134","source":"Crossref","is-referenced-by-count":15,"title":["Intrathecal chemotherapy in lymphomatous meningitis"],"prefix":"10.1016","volume":"79","author":[{"given":"Fabio","family":"Canova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Trentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Sold\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ghiotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savina Maria Luciana","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.critrevonc.2010.07.005_bib0005","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.hoc.2005.05.003","article-title":"Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma","volume":"19","author":"Bierman","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"November\u2013December (6)","key":"10.1016\/j.critrevonc.2010.07.005_bib0010","first-page":"367","article-title":"Leptomeningeal metastasis","volume":"31","author":"O\u2019Meara","year":"2007","journal-title":"Curr Probl Cancer"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2010.07.005_bib0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2008.16.8021","article-title":"Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 \u2013 The Southwest Oncology Group","volume":"27","author":"Bernstein","year":"2009","journal-title":"J Clin Oncol"},{"issue":"October (7)","key":"10.1016\/j.critrevonc.2010.07.005_bib0020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/1097-0142(19831001)52:7<1301::AID-CNCR2820520728>3.0.CO;2-5","article-title":"Intracranial Hodgkin's disease. A report of 12 cases and review of the literature","volume":"52","author":"Sapozink","year":"1983","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2010.07.005_bib0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2257.1989.tb00231.x","article-title":"Central nervous system involvement in haematological malignancies","volume":"11","author":"Sheehan","year":"1989","journal-title":"Clin Lab Haematol"},{"issue":"December (6)","key":"10.1016\/j.critrevonc.2010.07.005_bib0030","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00000421-199112000-00004","article-title":"Central nervous system involvement in patients with diffuse aggressive non-Hodgkin's lymphoma","volume":"14","author":"Bashir","year":"1991","journal-title":"Am J Clin Oncol"},{"issue":"November (5\u20136)","key":"10.1016\/j.critrevonc.2010.07.005_bib0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428199609054867","article-title":"Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients","volume":"23","author":"Zinzani","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"November (6)","key":"10.1016\/j.critrevonc.2010.07.005_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.blre.2006.02.001","article-title":"CNS prophylaxis in lymphoma: who to target and what therapy to use","volume":"20","author":"Hill","year":"2006","journal-title":"Blood Rev"},{"issue":"February (4)","key":"10.1016\/j.critrevonc.2010.07.005_bib0045","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","article-title":"Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma","volume":"91","author":"van Besien","year":"1998","journal-title":"Blood"},{"issue":"July (7)","key":"10.1016\/j.critrevonc.2010.07.005_bib0050","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mdf175","article-title":"Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model","volume":"13","author":"Hollender","year":"2002","journal-title":"Ann Oncol"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2010.07.005_bib0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008394827806","article-title":"Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients","volume":"11","author":"Haioun","year":"2000","journal-title":"Ann Oncol"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2010.07.005_bib0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdh013","article-title":"Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab","volume":"15","author":"Feugier","year":"2004","journal-title":"Ann Oncol"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2010.07.005_bib0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdl327","article-title":"Incidence and risk factors of central nervous system recurrence in aggressive lymphoma\u2013a survey of 1693 patients treated in protocols of the German high-grade non-Hodgkin's lymphoma study group (DSHNHL)","volume":"18","author":"Boehme","year":"2007","journal-title":"Ann Oncol"},{"issue":"September (9)","key":"10.1016\/j.critrevonc.2010.07.005_bib0070","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00277-008-0682-6","article-title":"Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement","volume":"88","author":"Lee","year":"2009","journal-title":"Ann Hematol"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2010.07.005_bib0075","first-page":"96","article-title":"Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation","volume":"91","author":"Barosi","year":"2006","journal-title":"Haematologica"},{"issue":"February (3)","key":"10.1016\/j.critrevonc.2010.07.005_bib0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/1097-0142(19800201)45:3<545::AID-CNCR2820450322>3.0.CO;2-6","article-title":"CNS involvement in the non-Hodgkin's lymphomas","volume":"45","author":"Levitt","year":"1980","journal-title":"Cancer"},{"issue":"October (1)","key":"10.1016\/j.critrevonc.2010.07.005_bib0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2005.05703.x","article-title":"Central nervous system-directed preventative therapy in adults with lymphoma","volume":"131","author":"McMillan","year":"2005","journal-title":"Br J Haematol"},{"issue":"October (2)","key":"10.1016\/j.critrevonc.2010.07.005_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2141.2005.05756.x","article-title":"Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK","volume":"131","author":"Cheung","year":"2005","journal-title":"Br J Hematol"},{"issue":"October (12)","key":"10.1016\/j.critrevonc.2010.07.005_bib0095","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1157\/13126952","article-title":"Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain","volume":"131","author":"Sancho","year":"2008","journal-title":"Med Clin (Barc)"},{"issue":"December (4)","key":"10.1016\/j.critrevonc.2010.07.005_bib0100","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/beha.2002.0230","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"15","author":"Hoelzer","year":"2002","journal-title":"Best Pract Res Clin Haematol"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2010.07.005_bib0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3324\/haematol.11767","article-title":"Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART","volume":"93","author":"Navarro","year":"2008","journal-title":"Haematologica"},{"issue":"March (6)","key":"10.1016\/j.critrevonc.2010.07.005_bib0110","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/cncr.24922","article-title":"Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma","volume":"116","author":"Spina","year":"2010","journal-title":"Cancer"},{"issue":"March (2)","key":"10.1016\/j.critrevonc.2010.07.005_bib0115","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.transproceed.2004.12.130","article-title":"Posttransplant lymphoproliferative disorder: significance of central nervous system involvement","volume":"37","author":"Buell","year":"2005","journal-title":"Transplant Proc"},{"issue":"November (5)","key":"10.1016\/j.critrevonc.2010.07.005_bib0120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1600-0609.1985.tb02817.x","article-title":"Meningeal involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment","volume":"35","author":"Ersb\u00f8ll","year":"1985","journal-title":"Scand J Haematol"},{"issue":"April (4)","key":"10.1016\/j.critrevonc.2010.07.005_bib0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0277-5379(89)90207-1","article-title":"Central nervous system involvement in non-Hodgkin's lymphoma","volume":"25","author":"Liang","year":"1989","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.07.005_bib0130","first-page":"200","article-title":"Central nervous system lymphoma","volume":"14","author":"Ferreri","year":"2007","journal-title":"Lymphoma: Pathol Diagn Treat"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2010.07.005_bib0135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/1042819031000067909","article-title":"CNS prophylaxis and treatment in non-Hodgkin's lymphoma: variation in practice and lessons from the literature","volume":"44","author":"Buckstein","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"August (8)","key":"10.1016\/j.critrevonc.2010.07.005_bib0140","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead","year":"2002","journal-title":"Ann Oncol"},{"issue":"May (5)","key":"10.1016\/j.critrevonc.2010.07.005_bib0145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1590\/S0100-879X2004000500014","article-title":"A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group","volume":"37","author":"Santini","year":"2004","journal-title":"Braz J Med Biol Res"},{"issue":"April (8)","key":"10.1016\/j.critrevonc.2010.07.005_bib0150","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2006-08-043646","article-title":"Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia","volume":"109","author":"Jabbour","year":"2007","journal-title":"Blood"},{"issue":"September (5)","key":"10.1016\/j.critrevonc.2010.07.005_bib0155","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood-2007-02-073536","article-title":"Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia","volume":"110","author":"Chamberlain","year":"2007","journal-title":"Blood"},{"issue":"September (5)","key":"10.1016\/j.critrevonc.2010.07.005_bib0160","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood-2007-04-081745","article-title":"Neurologic toxicity of intrathecal liposomal cytarabine when used for CNS prophylaxis in conjunction with the hyper-CVAD regimen","volume":"110","author":"Thomas","year":"2007","journal-title":"Blood"},{"issue":"February (2)","key":"10.1016\/j.critrevonc.2010.07.005_bib0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V55.2.199.199","article-title":"Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis","volume":"55","author":"Omura","year":"1980","journal-title":"Blood"},{"issue":"September (6)","key":"10.1016\/j.critrevonc.2010.07.005_bib0170","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1182\/blood.V86.6.2091.bloodjournal8662091","article-title":"The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia","volume":"86","author":"Cortes","year":"1995","journal-title":"Blood"},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2010.07.005_bib0175","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.1983.1.11.677","article-title":"Central nervous system involvement in American Burkitt's lymphoma","volume":"1","author":"Sariban","year":"1983","journal-title":"J Clin Oncol"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2010.07.005_bib0180","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.1986.4.6.847","article-title":"Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types)","volume":"4","author":"Bernstein","year":"1986","journal-title":"J Clin Oncol"},{"issue":"December (13)","key":"10.1016\/j.critrevonc.2010.07.005_bib0185","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2003-02-0542","article-title":"Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma","volume":"102","author":"Tilly","year":"2003","journal-title":"Blood"},{"issue":"August (3)","key":"10.1016\/j.critrevonc.2010.07.005_bib0190","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/cncr.10699","article-title":"Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-Hodgkin lymphoma","volume":"95","author":"Tomita","year":"2002","journal-title":"Cancer"},{"issue":"June\u2013July (2\u20133)","key":"10.1016\/j.critrevonc.2010.07.005_bib0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1005963732481","article-title":"Meningeosis leukaemica in adult acute lymphoblastic leukaemia","volume":"38","author":"G\u00f6kbuget","year":"1998","journal-title":"J Neurooncol"},{"issue":"February (2)","key":"10.1016\/j.critrevonc.2010.07.005_bib0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1200\/JCO.1983.1.2.91","article-title":"Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)","volume":"1","author":"Skarin","year":"1983","journal-title":"J Clin Oncol"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2010.07.005_bib0205","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1200\/JCO.1990.8.1.84","article-title":"The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen","volume":"8","author":"Shipp","year":"1990","journal-title":"J Clin Oncol"},{"issue":"March (5)","key":"10.1016\/j.critrevonc.2010.07.005_bib0210","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/1097-0142(19860301)57:5<971::AID-CNCR2820570516>3.0.CO;2-X","article-title":"Central nervous system prophylaxis with combined intravenous and intrathecal methotrexate in diffuse lymphoma of aggressive histologic type","volume":"57","author":"Perez-Soler","year":"1986","journal-title":"Cancer"},{"issue":"February (2)","key":"10.1016\/j.critrevonc.2010.07.005_bib0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)","volume":"9","author":"Pfreundschuh","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2010.07.005_bib0220","first-page":"158","article-title":"CNS recurrence in aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without Rituximab: an anlysis of CNS events in elderly patients treated in the ricover-60 trial of the German high-grade non-Hodgkin's lymphoma study group (DSHNHL)","volume":"398","author":"Schmitz","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.critrevonc.2010.07.005_bib0225","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/02841869609084002","article-title":"Risk factors for central nervous system involvement in non-Hodgkins-lymphoma\u2014a multivariate analysis","volume":"35","author":"Keldsen","year":"1996","journal-title":"Acta Oncol"},{"issue":"July (7)","key":"10.1016\/j.critrevonc.2010.07.005_bib0230","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archneur.1997.00550190044013","article-title":"Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients","volume":"54","author":"Bollen","year":"1997","journal-title":"Arch Neurol"},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2010.07.005_bib0235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00277-008-0645-y","article-title":"Intrathecal chemotherapy for Hematologic malignancies: drugs and toxicities","volume":"88","author":"Kwong","year":"2009","journal-title":"Ann Hematol"},{"issue":"December (12)","key":"10.1016\/j.critrevonc.2010.07.005_bib0240","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.1986.4.12.1845","article-title":"Transient cerebral dysfunction secondary to high-dose methotrexate","volume":"4","author":"Walker","year":"1986","journal-title":"J Clin Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2010.07.005_bib0245","first-page":"89","article-title":"Neurologic sequelae of methotrexate and ionizing radiation: a new classification","volume":"65","author":"Bleyer","year":"1981","journal-title":"Cancer Treat Rep"},{"issue":"April (4)","key":"10.1016\/j.critrevonc.2010.07.005_bib0250","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.1986.4.4.571","article-title":"Neurotoxicity associated with systemic high-dose cytosine arabinoside","volume":"4","author":"Nand","year":"1986","journal-title":"J Clin Oncol"},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2010.07.005_bib0255","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1200\/JCO.1996.14.11.3036","article-title":"Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies","volume":"14","author":"van Besien","year":"1996","journal-title":"J Clin Oncol"},{"issue":"November (11)","key":"10.1016\/j.critrevonc.2010.07.005_bib0260","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1200\/JCO.1994.12.11.2415","article-title":"Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome\u2014a report by the European Bone Marrow Transplant Lymphoma Registry","volume":"12","author":"Williams","year":"1994","journal-title":"J Clin Oncol"},{"issue":"3A","key":"10.1016\/j.critrevonc.2010.07.005_bib0265","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1083-8791(00)70060-7","article-title":"High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma","volume":"6","author":"Alvarnas","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.critrevonc.2010.07.005_bib0270","series-title":"Abeloff's clinical oncology","first-page":"827","article-title":"Brain metastases and neoplastic meningitis","author":"Sneed","year":"2008"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2010.07.005_bib0275","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11912-003-0084-9","article-title":"Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis","volume":"5","author":"Berg","year":"2003","journal-title":"Curr Oncol Rep"},{"issue":"June (16)","key":"10.1016\/j.critrevonc.2010.07.005_bib0280","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1200\/JCO.2006.09.9861","article-title":"Chemotherapy delivery issues in central nervous system malignancy: a reality check","volume":"25","author":"Muldoon","year":"2007","journal-title":"J Clin Oncol"},{"issue":"January (1)","key":"10.1016\/j.critrevonc.2010.07.005_bib0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/oxfordjournals.annonc.a057826","article-title":"Concentrations of VP16 and VM26 in human brain tumors","volume":"2","author":"Zucchetti","year":"1991","journal-title":"Ann Oncol"},{"issue":"March (6)","key":"10.1016\/j.critrevonc.2010.07.005_bib0290","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/cncr.10397","article-title":"Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing: a surrogate marker of brain penetration","volume":"94","author":"Kellie","year":"2002","journal-title":"Cancer"},{"issue":"October (10)","key":"10.1016\/j.critrevonc.2010.07.005_bib0295","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","article-title":"A randomized trial of a slow-release formulation of cytarabine for the treatment of lymphomatous meningitis","volume":"17","author":"Glantz","year":"1999","journal-title":"J Clin Oncol"},{"issue":"January (2)","key":"10.1016\/j.critrevonc.2010.07.005_bib0300","first-page":"197","article-title":"Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma","volume":"81","author":"Antonini","year":"2007","journal-title":"J Neurooncol"},{"issue":"June (6)","key":"10.1016\/j.critrevonc.2010.07.005_bib0305","first-page":"753","article-title":"Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab","volume":"89","author":"Schulz","year":"2004","journal-title":"Haematologica"},{"issue":"September (3)","key":"10.1016\/j.critrevonc.2010.07.005_bib0310","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1019999830455","article-title":"Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using Rituximab","volume":"59","author":"Pels","year":"2002","journal-title":"J Neurooncol"},{"issue":"April (11)","key":"10.1016\/j.critrevonc.2010.07.005_bib0315","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2006.09.7311","article-title":"Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma","volume":"25","author":"Rubenstein","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.critrevonc.2010.07.005_bib0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00043426-198921000-00019","article-title":"Neurotoxicity due to central nervous system therapy for childhood leukemia","volume":"11","author":"Ochs","year":"1989","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"October (15)","key":"10.1016\/j.critrevonc.2010.07.005_bib0325","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM197310112891503","article-title":"Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia","volume":"289","author":"Bleyer","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2010.07.005_bib0330","series-title":"Central nervous system leukemia","first-page":"71","article-title":"Therapy related central nervous system diseases in children with acute lymphocytic leukemia","author":"Price","year":"1983"},{"issue":"Spring (1)","key":"10.1016\/j.critrevonc.2010.07.005_bib0335","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00043426-198921000-00017","article-title":"Central nervous system pharmacology of antileukemic drugs","volume":"11","author":"Balis","year":"1989","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2010.07.005_bib0340","first-page":"89","article-title":"Neurologic sequelae of methotrexate and ionizing radiation: a new classification","volume":"65","author":"Bleyer","year":"1981","journal-title":"Cancer Treat Rep"},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2010.07.005_bib0345","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0360-3016(01)02701-8","article-title":"Staging and management of localized non-Hodgkin's lymphomas: variation among experts in radiation oncology","volume":"52","author":"Tsang","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"July (21)","key":"10.1016\/j.critrevonc.2010.07.005_bib0350","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2007.12.5088","article-title":"CNS involvement in Hodgkin's lymphoma","volume":"25","author":"Re","year":"2007","journal-title":"J Clin Oncol"},{"issue":"September (5)","key":"10.1016\/j.critrevonc.2010.07.005_bib0355","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2008-04-151563","article-title":"CNS Hodgkin lymphoma","volume":"112","author":"Gerstner","year":"2008","journal-title":"Blood"},{"issue":"August (8)","key":"10.1016\/j.critrevonc.2010.07.005_bib0360","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/10428190410001673409","article-title":"Intracranial presentation of systemic Hodgkin's disease","volume":"45","author":"Hirmiz","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"February (2)","key":"10.1016\/j.critrevonc.2010.07.005_bib0365","first-page":"149","article-title":"Hodgkin lymphoma with leptomeningeal involvement","volume":"81","author":"Malhotra","year":"2006","journal-title":"Am J Hematol"},{"issue":"December (10)","key":"10.1016\/j.critrevonc.2010.07.005_bib0370","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/oxfordjournals.annonc.a010501","article-title":"Meningeal localization in a patient with Hodgkin's disease: description of a case and review of the literature","volume":"7","author":"Anselmo","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2010.07.005_bib0375","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000478-199904000-00014","article-title":"Primary intracerebral Hodgkin's disease","volume":"April (243)","author":"Klein","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"October (20)","key":"10.1016\/j.critrevonc.2010.07.005_bib0380","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1200\/JCO.2004.01.163","article-title":"Unusual sites of Hodgkin's lymphoma: CASE 2. Hodgkin's lymphoma of the CNS masquerading as meningioma","volume":"22","author":"Figueroa","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2010.07.005_bib0385","article-title":"Central nervous system involvement in diffuse large B-cell lymphoma","volume":"March","author":"Yamamoto","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.critrevonc.2010.07.005_bib0390","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12185-009-0289-2","article-title":"Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience","volume":"89","author":"Shimazu","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.critrevonc.2010.07.005_bib0395","article-title":"Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy","author":"Villa","year":"2009","journal-title":"Ann Oncol"},{"issue":"June (2)","key":"10.1016\/j.critrevonc.2010.07.005_bib0400","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hon.881","article-title":"Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options","volume":"27","author":"Ferreri","year":"2009","journal-title":"Hematol Oncol"},{"issue":"September (9)","key":"10.1016\/j.critrevonc.2010.07.005_bib0405","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1080\/1042819021000006475","article-title":"Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma","volume":"43","author":"Chua","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"February (3)","key":"10.1016\/j.critrevonc.2010.07.005_bib0410","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/1097-0142(19820201)49:3<586::AID-CNCR2820490331>3.0.CO;2-C","article-title":"Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases","volume":"49","author":"MacKintosh","year":"1982","journal-title":"Cancer"},{"issue":"February (2)","key":"10.1016\/j.critrevonc.2010.07.005_bib0415","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1008260120532","article-title":"For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group","volume":"9","author":"Bos","year":"1998","journal-title":"Ann Oncol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810001721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842810001721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T06:15:45Z","timestamp":1711692945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842810001721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1040842810001721"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2010.07.005","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}